Visipaque 270mg I/mL Injection
Iodixanol, Trometamol
"550mg, 1.2mg/ml"
GE HEALTHCARE IRELAND
| Pack size | 100ml Glass Bottle x 10 |
|---|---|
| Dispensing mode | POM |
| Source | IRELAND |
| Agent | CITY MEDICAL STORE |
| Retail Price | 2079.00 AED |
Available as:
Indications
Visipaque 270mg I/mL Injection is used for:
IODIXANOL
Iodixanol is a contrast agent during coronary angiography
TROMETAMOL
. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer
Iodixanol is a contrast agent during coronary angiography
TROMETAMOL
. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Iodixanol, Trometamol :
Mechanism of Action
IODIXANOL
Organic iodine compounds attenuate x-rays as they pass through the body, thereby allowing the body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. After intravascular administration, iodixanol makes opaque those internal structures in its path of flow, allowing their visualization until significant hemodilution and elimination occur
Organic iodine compounds attenuate x-rays as they pass through the body, thereby allowing the body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. After intravascular administration, iodixanol makes opaque those internal structures in its path of flow, allowing their visualization until significant hemodilution and elimination occur
Note
Visipaque 270mg I/mL "550mg, 1.2mg/ml" Injection manufactured by GE HEALTHCARE IRELAND. Its generic name is Iodixanol, Trometamol. Visipaque 270mg I/mL is availble in United Arab Emirates.
Farmaco UAE drug index information on Visipaque 270mg I/mL Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Iodixanol, Trometamol :
Injection
Visipaque 320mg I/mL
"625mg, 1.2mg/ml"
AMERSHAM HEALTH
Injection
Visipaque 320mg I/mL
"625mg, 1.2mg/ml"
AMERSHAM HEALTH
Injection
Visipaque 320mg I/mL
"625mg, 1.2mg/ml"
AMERSHAM HEALTH
Injection
Visipaque 270mg I/mL
"550mg, 1.2mg/ml"
GE HEALTHCARE IRELAND
Injection
Visipaque 270mg I/mL
"305mg, 1.2mg/ml"
AMERSHAM HEALTH